FLUTIFORM

Main information

  • Trade name:
  • FLUTIFORM Pressurised inhalation, suspension 50MCG/5MCG/DÁV
  • Dosage:
  • 50MCG/5MCG/DÁV
  • Pharmaceutical form:
  • Pressurised inhalation, suspension
  • Administration route:
  • Inhalation use
  • Units in package:
  • 3 Metering valve
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FLUTIFORM Pressurised inhalation, suspension 50MCG/5MCG/DÁV
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • FORMOTEROL AND FLUTICASONE
  • Product summary:
  • FLUTIFORM

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 14/ 553/12-C
  • Last update:
  • 16-01-2018

7-8-2018

Duaklir Genuair (AstraZeneca AB)

Duaklir Genuair (AstraZeneca AB)

Duaklir Genuair (Active substance: aclidinium bromide / formoterol fumarate dihydrate) - Centralised - Yearly update - Commission Decision (2018)5419 of Tue, 07 Aug 2018

Europe -DG Health and Food Safety

7-8-2018

Brimica Genuair (AstraZeneca AB)

Brimica Genuair (AstraZeneca AB)

Brimica Genuair (Active substance: aclidinium bromide / formoterol fumarate dihydrate) - Centralised - Yearly update - Commission Decision (2018)5420 of Tue, 07 Aug 2018

Europe -DG Health and Food Safety